CFDE Data Portal | Search MTND2P31

	Label	Description
	MTND2P31 associations Collection (Entity type)	Associations for MTND2P31_associations
	MTND2P31 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	MTND2P31 Gene (Entity type)	ENSG00000251252 - MT-ND2 pseudogene 31
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 1 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 1 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	SCNN1D IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	PLK5 IDG kinase ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	CLCNKA IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE199862 Chk1 inhibition 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE139540 menadione 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

MTND2P31 associations

Associations for MTND2P31_associations

MTND2P31 associations.tsv

A file from IDG as part of the Harmonizome project

MTND2P31

ENSG00000251252 - MT-ND2 pseudogene 31

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 1 v 10 human up

A Gene Set from LINCS

GSE76425 lenalidomide 1 v 10 human up

A Gene Set from LINCS

SCNN1D IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

PLK5 IDG kinase ARCHS4 coexpression

A Gene Set from IDG

CLCNKA IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

GSE199862 Chk1 inhibition 0 v 2 human up

A Gene Set from LINCS

GSE139540 menadione 3 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.